---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-035316"
form_type: "8-K"
ticker: "SIGA"
cik: "0001010086"
company_name: "SIGA TECHNOLOGIES INC"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:35:27.676250+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SIGA Q2 product sales $20.7M, net income $1.8M; receives $113M U.S. order in July

## Summary
- Product sales $20.7M in Q2 (vs $1.3M prior year); total revenues $21.8M; net income $1.8M or $0.03 diluted EPS.
- Received $113M procurement order from U.S. government for oral TPOXX in July 2024 under BARDA contract.
- Delivered $18M of IV TPOXX to U.S. SNS in Q2; $3M oral TPOXX to new ASEAN customer.
- Paid special cash dividend of $0.60 per share on April 11, 2024, up $0.15 from prior year.
- Amendment with Meridian gives SIGA control over international promotion of oral TPOXX effective June 1, 2024.

## SEC filing metadata
- accession: 0001140361-24-035316
- form_type: 8-K
- ticker: SIGA
- cik: 0001010086
- company_name: SIGA TECHNOLOGIES INC
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1010086/000114036124035316/0001140361-24-035316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1010086/000114036124035316/ef20033337_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-035316
- JSON: https://secwatch.observer/filing/0001140361-24-035316.json
- Plain text: https://secwatch.observer/filing/0001140361-24-035316.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.